Finally, Kaplan–Meier analysis revealed that HCC patients with high expression of NPAS2 had significantly poorer OS and recurrence-free survival (RFS) than those with low expression (log rank P=0.010 and 0.035, Figures 1d and e). The gene discussed is NPAS2; the disease is hepatocellular carcinoma.